News

uniQure announced that its Board of Directors has unanimously approved the appointment of Matthew Kapusta as Chief Executive Officer (CEO) of the Company, effective immediately. Mr.…
Read More...

A jury in the US District Court for the District of Delaware ordered Gilead Sciences to pay $2.54bn in damages to Merck's subsidiary Idenix Pharmaceuticals for infringing its patents in…
Read More...

GSK is opening a new global vaccines research and development (R&D) center in Rockville, Maryland, US. Up to 200 new jobs will be created at the Rockville facility, with GSK…
Read More...

US drug developer Alexion Pharmaceuticals has named David Brennan as interim CEO, effective immediately. Brennan is the former Chief Executive Officer and Executive Director of…
Read More...

West Pharmaceutical Services has completed a 60,000ft² expansion at its contract manufacturing facility near Mulhuddart, County Dublin, Ireland. The expansion is in response to…
Read More...

Patheon, a global provider of pharmaceutical development and manufacturing services, has agreed to acquire an active pharmaceutical ingredients (API) manufacturing facility in Florence,…
Read More...

Menarini-Silicon Biosystems said its DEPArray single-cell isolation technology played an important role in a study carried out by researchers from The University of Manchester to…
Read More...

Neovacs has partnered with 3P Biopharmaceuticals to manufacture interferon alpha (IFNα) cytokine. The collaboration follows the recent acquisition of the technology for the…
Read More...

Sun Pharma has agreed to acquire 85.1% stake in JSC Biosintez, a Russian pharmaceutical firm engaged in manufacture and marketing of pharmaceutical products in Russia and CIS region.…
Read More...

Tillotts Pharma has introduced a new advanced enteric coating for solid dosage forms at this year's annual meeting of the American Association of Pharmaceutical Scientists. The…
Read More...

Marinus Pharmaceuticals presented preclinical data showing that the combination of its CNS-selective GABAA modulator ganaxolone and diazepam administered intravenously (IV) produced a…
Read More...

PAREXEL International has launched an Identification of Medicinal Products (IDMP)-focused solution for biopharmaceutical companies. LIQUENT InSight for IDMP is the newest module…
Read More...

UK artificial intelligence (AI) firm BenevolentAI has signed an exclusive license for a series of novel clinical stage drug candidates with Janssen Pharmaceutica (Janssen), one of the…
Read More...

DNAtrix, a clinical stage biotechnology company developing virus-driven immunotherapies for cancer, announced it has entered into an exclusive license agreement with the University of…
Read More...

The international technology group Körber, headquartered in Hamburg, Germany, is planning to acquire the company Fargo Automation, Inc., based in Fargo, North Dakota, USA. Fargo…
Read More...

ERS Genomics and Knudra Transgenics have signed a non-exclusive license agreement on CRISPR-Cas9 genome editing patents for model organisms. The deal provides Knudra with worldwide…
Read More...

DNAtrix, a clinical stage biotechnology company developing virus-driven immunotherapies for cancer, announced that the first patients have been treated in a multicenter Phase 2 trial…
Read More...

Portola Pharmaceuticals (PTLA) has expanded its existing clinical collaboration agreement with Daiichi Sankyo to develop AndexXa (andexanet alfa) as an antidote for the former’s Factor…
Read More...

Nimbus Therapeutics secured a $200m from Gilead Sciences in a payment related to the latter’s allosteric Acetyl-CoA Carboxylase (ACC) inhibitor program with NDI-010976 (now GS-0976)…
Read More...

Celgene and IBM Watson Health will co-develop a new offering that aims to enhance pharmacovigilance methods used to collect, assess, monitor, and report adverse drug reactions. The…
Read More...